Acquisition of a new ultrasound imaging system for advanced cardiovascular and cancer research
Official title: Request for the Acquisition of a Vevo F2 Ultrasound Imaging System
Funded at East Tennessee State University · NIH-11102626 · Data updated 2026-11-12
This study is all about getting a new, high-tech ultrasound machine to help doctors and researchers at East Tennessee State University take better pictures of the heart and cancer, making it easier to track health changes over time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | East Tennessee State University NIH-funded |
| Lab location | 1 site (Johnson City, United States) |
| Project start | May 1, 2025 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $481,800 |
| NIH project number | 1S10OD038302-01 |
| Project ID | NIH-11102626 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include pediatric and adult patients with cardiovascular conditions or cancers who may be involved in studies utilizing the new imaging technology.
✕Less likely to help
Patients with conditions that do not require advanced ultrasound imaging or those outside the age range of 10 years may not receive direct benefits from this research.
What this research studies
This research involves acquiring the Vevo F2 ultrasound imaging system to enhance imaging capabilities for cardiovascular and cancer studies at East Tennessee State University. The new system will replace an outdated model and provide advanced features such as high-definition imaging, 4D imaging, and artificial intelligence algorithms for improved image analysis. This upgrade will support both established NIH-funded researchers and junior faculty seeking funding, facilitating a wide range of studies in heart and vascular health as well as oncology. The system aims to generate clearer images and enable dynamic monitoring of conditions over time.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic capabilities and treatment monitoring for patients with cardiovascular diseases and cancers.
How similar studies have gone: Other research has shown success with advanced ultrasound imaging systems, indicating that this approach has the potential for significant advancements in patient care.
Where this research is happening
-
East Tennessee State University
Johnson City, United States Active
Researchers
- Principal investigator: Wang, Xiaohui — East Tennessee State University
- Study coordinator: Wang, Xiaohui
Related research
Other NIH-funded projects on the same topics.
-
Modulating deep brain activity with focused ultrasound for cocaine use disorder
A study will test whether targeting a deep brain region with focused ultrasound can alter brain signals related to craving in people with cocaine use disorder.
-
Dose-Dependent Brain Wire Modulation with Light Ultrasound in Deep White Matter
A small early study tests whether gentle, noninvasive ultrasound can change how deep brain white matter tracts work in healthy adults.
-
Ultrasound-guided brain circuit targets for treatment-resistant depression
This grant tests whether focused ultrasound can safely and reversibly adjust brain circuits linked to negative mood in people with treatment-resistant depression.
-
Ultrasound biomarkers to diagnose and predict treatment response for plantar heel pain
A study will test advanced ultrasound imaging to find biomarkers that help diagnose plantar heel pain and predict who will respond to targeted treatments.
-
Brain ultrasound and microcirculation to understand early brain development in HIV-exposed uninfected infants
We’re studying how brain ultrasound and blood flow patterns in newborns exposed to HIV and antiretroviral drugs (but not infected) relate to their early neurodevelopment.
-
A 3D ultrasound scanner to see early chemotherapy response in breast cancer
A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.